Takaaki Senbonmatsu

Prof. Dr. Takaaki Senbonmatsu

Department of Cardiology, Saitama Medical University, Iruma District, Kawagoe, Japan
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2011 in Hypertension Research
Verified
Journal Article
Closed access
XSXiao Sun
Xiao Sun
SIShinichiro Iida
Shinichiro Iida
AYAyumu Yoshikawa
Ayumu Yoshikawa
RSRina Senbonmatsu
Rina Senbonmatsu
KIKazuhito Imanaka
Kazuhito Imanaka
Takaaki SenbonmatsuTakaaki Senbonmatsu
Takaaki Senbonmatsu

1 March 2017 in Journal of Pharmacological Sciences
Verified
Journal Article
Open access
KSKaname Seki
Kaname Seki
YMYosuke Mizuno
Yosuke Mizuno
TSToku Sakashita
Toku Sakashita
SNShintaro Nakano
Shintaro Nakano
JTJun Tanno
Jun Tanno
Takaaki SenbonmatsuTakaaki Senbonmatsu
Takaaki Senbonmatsu
Activated factor X (FXa) plays an important role in thrombin generation and inflammation. Factor X is not converted constitutively to FXa, but only after intrinsic clotting factors are activated and/or cellular injury occurs. Although rivaroxaban is one of direct FXa inhibitors, its function in the inactivated coagulation cascade is unclear. In human umbilical vein endothelial cells that natively express protease-activated receptor-1 and -2, high dose rivaroxaban did not alter gene transcripts including pro-inflammatory genes in DNA microarray. Upon FXa stimulation, the expressions of pro-inflammatory genes such as monocyte chemoattractant protein-1 (MCP-1), intracellular adhesion molecule-1, and interleukin-8 were maximally increased at 4 h after stimulation, and were suppressed by rivaroxaban. To confirm these results, quantitative polymerase chain reaction and enzyme-linked immunosorbent assay (ELISA) for MCP-1 were performed. FXa evoked the expression of MCP-1 maximally at 4 h after stimulation, whereas MCP-1 displayed a different temporal activation in ELISA. Interestingly, rivaroxaban inhibited both time courses of MCP-1 expression. These results suggest that rivaroxaban may not influence gene modulation in the inactivated coagulation state, but can attenuate the endothelial damage evoked by FXa and pro-inflammatory cytokine genes.

Verified
Journal Article
Open access
PDF file
NTNaomichi Tanaka
Naomichi Tanaka
HKHidemasa Kato
Hidemasa Kato
HTHiromi Tsuda
Hiromi Tsuda
YSYasunori Sato
Yasunori Sato
TMToshihiro Muramatsu
Toshihiro Muramatsu
Takaaki SenbonmatsuTakaaki Senbonmatsu
Takaaki Senbonmatsu
Induced pluripotent stem (iPS) cells are a type of artificial pluripotent stem cell induced by the epigenetic silencing of somatic cells by the Yamanaka factors. Advances in iPS cell reprogramming technology will allow aging or damaged cells to be replaced by a patient’s own rejuvenated cells. However, tissue that is senescent or pathologic has a relatively low reprogramming efficiency as compared with juvenile or robust tissue, resulting in incomplete reprogramming; iPS cells generated from such tissue types do not have sufficient differentiation ability and are therefore difficult to apply clinically. Here, we develop a new reprogramming method and examine it using myofibroblasts, which are pathologic somatic cells, from patient skin tissue and from each of the four heart chambers of a recipient heart in heart transplant surgery. By adjusting the type and amount of vectors containing transcriptional factors for iPS cell reprogramming, as well as adjusting the transfection load and culture medium, the efficiency of iPS cell induction from aged patient skin-derived fibroblasts was increased, and we successfully induced iPS cells from myocardial fibroblasts isolated from the pathologic heart of a heart transplant recipient.

19 December 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
IYIkeda Yoshifumi
Ikeda Yoshifumi
KTKenta Tsutsui
Kenta Tsutsui
YYYoshihiro Yamada
Yoshihiro Yamada
RKRitsushi Kato
Ritsushi Kato
TMToshihiro Muramatsu
Toshihiro Muramatsu
Takaaki SenbonmatsuTakaaki Senbonmatsu
Takaaki Senbonmatsu
The (pro)renin receptor ((P)RR), which evokes renin activity with prorenin, is secreted extracellularly as soluble (P)RR (s(P)RR) and may participate in tissue renin-angiotensin system (RAS) activity in severe heart failure (HF) patients. The aim of this study was to determine whether s(P)RR is an adequate marker in severe HF patients treated with RAS inhibitors, beta-blockers, and tolvaptan. We enrolled 11 patients with severe HF between May 2013 and June 2014. First of all, furosemide of all patients was changed to tolvaptan with hydrochlorothiazide and then the treatment had been changed according to the patient’s condition. After 1, 3, 6, and 12 months, the variance of s(P)RR, plasma renin activity (PRA), plasma renin concentration (PRC), brain natriuretic peptide (BNP) and their association was investigated. Furosemide was restarted in five patients and two patients suffered cardiac death. PRA/PRC and s(P)RR were unchanged (PRA: 10.7 ± 13.9 to 12.8 ± 8.5 ng/mL/h; PRC: 347.1 ± 577.5 to 148.3 ± 123.8 pg/mL; s(P)RR: 28.2 ± 19.3 to 33.4 ± 22.4 ng/mL) and had no significant correlations (PRA and s(P)RR: p = 0.36; PRC and s(P)RR: p = 0.35). There was a significant positive correlation with a high correlation coefficient (CC) between PRA and PRC (p < 0.0001, CC = 0.76), and a negative correlation with weak CC between BNP and s(P)RR (p = 0.01, CC = −0.45). In conclusion, s(P)RR was always high and had no correlations with disease state and PRA/PRC in severe HF patients.

7 October 2022 in Hypertension Research
Verified
Journal Article
Closed access
PDF file
Takaaki SenbonmatsuTakaaki Senbonmatsu
Takaaki Senbonmatsu

Verified
Journal Article
Open access
PDF file
YMYumi Mashimo
Yumi Mashimo
STSaki Tsuchihashi
Saki Tsuchihashi
KTKenta Tsutsui
Kenta Tsutsui
TATomoyuki Arai
Tomoyuki Arai
YTYoshitaka Tsuji
Yoshitaka Tsuji
Takaaki SenbonmatsuTakaaki Senbonmatsu
Takaaki Senbonmatsu
Maintaining a social environment that enables going out freely is important for older people and aids the prevention of frailty syndrome. However, losing a driver’s license can increase the long-term care needs of older people. Therefore, outing support systems are important. However, the utilization rate of these systems is currently relatively low. We conducted a demonstration experiment among older people aged 70 years and over, living in Iruma City, Saitama Japan, by implementing the Choisoko outing support system developed by Aisin Co., Ltd., in conjunction with an approach for improving motivation. Using this system, elderly people were able to go shopping freely whenever they chose, without a driver’s license. Participants in the demonstration experiment exhibited higher Functional Independence Measure scores after the intervention, irrespective of whether or not they used the Choisoko system. The number of uses per person increased over time, and the subjective well-being of Choisoko users improved. However, few male participants engaged with the system. Although improving motivation is important for inducing positive behaviors and enabling the elderly to go out, motivation-improving factors differ between men and women.